Branched chain amino acid

DIETARY_SUPPLEMENT5 trials

Sponsors

University of Western Ontario, Canada, Dayanand Medical College and Hospital, Chimei Medical Center, Post Graduate Institute of Medical Education and Research, Chandigarh, Institute of Liver and Biliary Sciences, India

Conditions

Acute-On-Chronic Liver FailureChronic Liver DiseaseHepatic EncephalopathyLiver CirrhosisSarcopenia

Phase 1

Intravenous Branched Chain Amino Acids for Hepatic Encephalopathy in ACLF

CompletedNCT04238416

Post Graduate Institute of Medical Education and Research, ChandigarhAcute-On-Chronic Liver Failure, Hepatic Encephalopathy

Start: 2019-11-01End: 2021-12-30Updated: 2022-08-16

Phase 3

Treatment of Sarcopenia Improves the Muscle Mass and Muscle Strength of Patients With Liver Cirrhosis-Child C

Active, not recruitingNCT03633279

Dayanand Medical College and HospitalLiver Cirrhosis

Start: 2018-06-22End: 2025-09-10Updated: 2025-06-27

Unknown Phase

Exercise and Branched Chain Amino Acids (BCAA)Requirements in Older Men

SuspendedNCT01931722

University of Western Ontario, CanadaSarcopenia

Start: 2016-01-31End: 2016-12-31Updated: 2016-01-12

Nutritional Intervention for Sarcopenia

CompletedNCT03891134

Chimei Medical CenterSarcopenia

Start: 2016-12-12End: 2017-06-08Updated: 2019-03-26

Effect of BCAA Supplementation on Muscle Mass, Muscle Quality and Molecular Markers of Muscle Regeneration in CLD Patients

CompletedNCT04246918

Institute of Liver and Biliary Sciences, IndiaChronic Liver Disease

Start: 2020-06-01End: 2022-09-30Updated: 2023-01-31

Related Papers

Intravenous BCAA Infusion Does Not Lead to a Sustained Recovery From Overt HE in ACLF - An Open Label Randomized Clinical Trial.

2023-06-015 citations